Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-08

Clinical Trial Update: Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl

View source ↗

Summary

This completed clinical trial evaluated whether vitamin D3 supplementation influences the risk of developing Long COVID after SARS-CoV-2 infection in individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Vitamin d Deficiency, COVID-19 | Status: COMPLETED